Metastatic Melanoma
Showing NaN - NaN of 32
Metastatic Melanoma Trial in New York (Lifileucel (LN-144))
Recruiting
- Metastatic Melanoma
- Lifileucel (LN-144)
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib
- +4 more
-
Phoenix, Arizona
- +48 more
Jan 3, 2023
Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)
Recruiting
- Metastatic Melanoma
- +2 more
- Lifileucel
- +5 more
-
La Jolla, California
- +44 more
Dec 16, 2022
Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)
Recruiting
- Unresectable Melanoma
- +3 more
- IOV-4001
-
Louisville, Kentucky
- +2 more
Nov 21, 2022
Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))
Recruiting
- Uveal Melanoma
- +3 more
- Lifileucel (LN-144)
-
Harrison, New York
- +1 more
Nov 8, 2022
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)
Available
- Unresectable Melanoma
- Metastatic Melanoma
- Lifileucel
-
Orlando, Florida
- +2 more
Jul 19, 2022
Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)
Completed
- Metastatic Melanoma
- Placebo for antibiotic
- +4 more
-
Los Angeles, California
- +6 more
Jun 7, 2022
Unresectable Melanoma, Metastatic Melanoma Trial in France, United States (Nivolumab, Ipilimumab, Placebo)
Completed
- Unresectable Melanoma
- Metastatic Melanoma
- Nivolumab
- +2 more
-
San Francisco, California
- +20 more
Feb 16, 2022
Metastatic Melanoma Trial in United States (ipilimumab, nivolumab)
Active, not recruiting
- Metastatic Melanoma
-
Hartford, Connecticut
- +11 more
Mar 10, 2022
Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558
Completed
- Metastatic Castration-resistant Prostrate Cancer
- +3 more
- BMS-936558 (MDX-1106)
-
Scottsdale, Arizona
- +12 more
Dec 1, 2021
Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))
Completed
- Metastatic Melanoma
- MORAb-004 (monoclonal antibody)
-
Scottsdale, Arizona
- +28 more
Aug 6, 2021
Metastatic Melanoma Trial in Worldwide (Lifileucel)
Active, not recruiting
- Metastatic Melanoma
- Lifileucel
-
La Jolla, California
- +56 more
Mar 24, 2021
Metastatic Melanoma Trial in United States (vemurafenib + HD IL-2)
Terminated
- Metastatic Melanoma
- vemurafenib + HD IL-2
-
Tucson, Arizona
- +20 more
Jan 28, 2021
Long-Term Quality of Life in Metastatic Melanoma Treated With
Completed
- Metastatic Melanoma
- EuroQoL EQ-5D-3L
- +5 more
-
Basking Ridge, New Jersey
- +5 more
Dec 15, 2020
Metastatic Melanoma Trial in United States (High Dose Interleukin-2, Ipilimumab)
Terminated
- Metastatic Melanoma
- High Dose Interleukin-2
- Ipilimumab
-
Tucson, Arizona
- +11 more
Dec 1, 2020
Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)
Completed
- Advanced Melanoma
- Metastatic Melanoma
- Nivolumab
- Ipilimumab
-
Los Angeles, California
- +13 more
Nov 14, 2019
Treatment Patterns and Clinical Response in Malignancy
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
-
Tucson, Arizona
- +44 more
Jun 11, 2019